3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
C18H14ClF3N4O4S — CID 156903079
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (PubChem CID 156903079) has the molecular formula C18H14ClF3N4O4S and a molecular weight of 474.85 g/mol. Its IUPAC name is 3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 156903079 |
| Molecular Formula | C18H14ClF3N4O4S |
| Molecular Weight | 474.85 g/mol |
| Exact Mass | 474.04 |
| IUPAC Name | 3-[6-[(3R)-1-(2-chlorophenyl)sulfonylpyrrolidin-3-yl]oxy-3-pyridinyl]-5-(trifluoromethyl)-1,2,4-oxadiazole |
| SMILES | O=S(=O)(c1ccccc1Cl)N1CC[C@@H](Oc2ccc(-c3noc(C(F)(F)F)n3)cn2)C1 |
| InChI | InChI=1S/C18H14ClF3N4O4S/c19-13-3-1-2-4-14(13)31(27,28)26-8-7-12(10-26)29-15-6-5-11(9-23-15)16-24-17(30-25-16)18(20,21)22/h1-6,9,12H,7-8,10H2/t12-/m1/s1 |
| InChIKey | GLPXPWXURBLPMF-GFCCVEGCSA-N |
| XLogP | 3.65 |
| TPSA | 98.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.85 |
| LogP ≤ 5 | 3.65 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156903079 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.